Publications by authors named "R S Hartz"

Claim this Profile
I
Invention of VH-937, a Potent HIV-1 Maturation Inhibitor with the Potential for Infrequent Oral Dosing in Humans.
Sing-Yuen Sit, Yan Chen, Jie Chen, Brian L Venables, Jacob J Swidorski, Richard A Hartz

ACS Med Chem Lett· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Profile of the HIV-1 Maturation Inhibitor VH3739937.
Brian McAuliffe, Paul Falk, Jie Chen, Yan Chen, Sing-Yuen Sit, Richard A Hartz

Viruses· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atropisomerism Observed in Galactose-Based Monosaccharide Inhibitors of Galectin-3 Comprising 2-Methyl-4-phenyl-2,4-dihydro-3-1,2,4-triazole-3-thione.
David S Yoon, Chunjian Liu, Prasada Rao Jalagam, Jianxin Feng, Wei Wang, Richard A Hartz

J Med Chem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 2-(Anilino)pyrimidine-4-carboxamides as Highly Potent, Selective, and Orally Active Glycogen Synthase Kinase-3 (GSK-3) Inhibitors.
Richard A Hartz, Vijay T Ahuja, Guanglin Luo, Ling Chen, Prasanna Sivaprakasam

J Med Chem· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Structure-Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2-]pyridazines as Glycogen Synthase Kinase-3β (GSK-3β) Inhibitors.
Richard A Hartz, Vijay T Ahuja, Prasanna Sivaprakasam, Hong Xiao, Carol M Krause

J Med Chem· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis